TORRANCE, Calif.--(BUSINESS WIRE)-- Fasha Mahjoor, founder and CEO of Phenomenex, a global leader in the separation sciences, has been appointed as one of “Outward Bound Trust’s 25 Strong Chairman’s Group members.” This newly formed team will meet in early June at Buckingham Palace with Outward Bound’s Chairman, HRH Duke of York, Prince Andrew.
Helping over a million young men and women realize their potential through outdoor physical challenges and trainings, The Outward Bound Trust is a UK charitable organization with local chapters throughout the world. When asked about the appointment, Mr. Mahjoor commented, “I am honored and particularly enthusiastic. The objective of Outward Bound to successfully develop young people into tomorrow’s leaders is in harmony with many of Phenomenex’s philanthropic endeavors.”
Despite the demands of a rapidly growing business, Mr. Mahjoor and the employees of Phenomenex companies have continued to dedicate tens of thousands of hours to support many charitable organizations throughout the world. “We are so proud of Fasha, and frankly not at all surprised that he is now amongst the ‘25 Strong Chairman’s group,’” stated Simon Lomas, co-leader of the Phenomenex philanthropy team. “He is incredibly talented at mobilizing both people and resources at a moment’s notice and is undaunted by seemingly insurmountable challenges.”
For more information on Outward Bound Trust, visit http://www.outwardbound.org.uk
Are you also passionate about giving back? Join us for one of our next humanitarian events at one of our Phenomenex companies throughout the world. Email email@example.com for more information.
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical, government and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being. For more information on Phenomenex, visit www.phenomenex.com.
Please send READER INQUIRIES from this news release directly to: firstname.lastname@example.org